Loading…
Loading…
INDIANAPOLIS, Oct. 26, 2026 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the fourth quarter of 2026 of $1.73 per share on outstanding common stock. The dividend is payable on December 10, 2026, to shareholders of record at the close of business on November 13, 2026.
Lilly and Merck boast blockbuster drugs, expanding pipelines and new growth opportunities but pricing pressure, patent risks & competition shape their outlooks.
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Lilly (LLY), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2026.
Cancer trial data shines at ESMO 2026, earnings flood after tough market week, and more…
TMO's organic growth of 5% exceeded consensus by 200 basis points, and management raised full-year organic growth guidance/. MTD's local-currency sales grew 6%, exceeding prior guidance of 3%. TEVA management raised guidance for all three brands.
Our top performer in the third quarter was TVA Group, which gained 46.7%. TVA's first-half earnings reached levels not seen in over a decade. Intercontinental Exchange advanced 23.5% in Q3, validating our view in Scorecard 54 that the regulatory panic surrounding perpetual futures was overdone. Portfolio stalwart Visa Inc. was our third-best contributor in Q3, advancing 4.7% as payment volumes and revenues sustained their double-digit growth.
Eli Lilly (NYSE:LLY | LLY Price Prediction) reports third-quarter results on October 29. It brings a streak of 5 consecutive EPS beats and a stock that has run hard into the report.